Featured
The Biotech Catalyst: How Synthetic Formulation and Regulatory Chokeholds are Bifurcating the Prestige Beauty Market
L'Oréal's $1.2B biotech acquisition and the EU's sweeping endocrine disruptor ban signal a ruthless bifurcation of the prestige beauty market. This a...
Read Full Story →